By Jonathan Landay WASHINGTON (Reuters) -The United States may reach a point in coming years where it will have to increase deployments of strategic nuclear
Year: 2024
Robinhood bets big on crypto with $200 million deal for Bitstamp
By Manya Saini (Reuters) -Trading platform Robinhood Markets said on Thursday it has agreed to buy crypto exchange Bitstamp for about $200 million in cash,
Lyft forecasts 15% annual growth in gross bookings through 2027
By Yuvraj Malik (Reuters) – Lyft is targeting 15% annual growth in gross bookings through 2027, the ride-hailing firm said at its inaugural investor day,
$1.3 billion UK lawsuit accuses Amazon of misusing small sellers’ data
LONDON (Reuters) – Amazon is facing a one billion-pound ($1.3 billion) collective lawsuit from British retailers who allege that the online marketplace misused their data
World stocks at record high after cautious ECB rate cut
By Marc Jones and Koh Gui Qing NEW YORK/LONDON (Reuters) -World stocks hit an all-time high and the euro rose on Thursday after the European
Stocks gain on rate cut bets as ECB meeting looms
By Danilo Masoni and Koh Gui Qing NEW YORK/MILAN (Reuters) -World shares rose and Treasury yields steadied on Wednesday as investors focused on an upcoming
Factbox-Trump’s second-term agenda: trade wars, mass deportations, destroying ‘deep state’
By James Oliphant, Gram Slattery WASHINGTON (Reuters) -Donald Trump plans to deport millions of migrants, reshape global trade with expensive tariffs and fill the government
Walmart to pay US hourly store workers bonuses for first time ever
(Reuters) – Walmart will, for the first time ever, pay bonuses to its U.S. hourly store workers, including those at its pharmacy and Vision Center
NBA nears rights deal worth $76 billion with NBC, ESPN and Amazon, WSJ reports
(Reuters) -The National Basketball Association is closing in on media rights deals with Comcast-owned NBC, Disney’s ESPN, and Amazon.com that would generate about $76 billion
J&J must pay $260 million in latest talc trial, Oregon jury says
By Brendan Pierson (Reuters) -Johnson & Johnson must pay $260 million to an Oregon woman who said she got mesothelioma, a deadly cancer linked to